Drug discovery for spinocerebellar ataxia, using novel fluorescence technology targeting B-III-spectrin

Project: Research project

Description

Drug discovery for spinocerebellar ataxia, using novel fluorescence technology targeting B-III-spectrin
StatusActive
Effective start/end date5/1/194/30/20

Funding

  • NIH NAT INST OF NEURO DISORDERS & STROKE

Fingerprint

Spectrin
Fluorescence
Drug Discovery